Welcome to Medications.com

GTXI: Additional Positive Data from Ph III Trial of Tremifene ... - Trading Markets (press release)

... in the Phase III ADT clinical trial experiencing six or more hot flashes per day at baseline and not being treated with megestrol acetate (Megace(R)), ...

Posted: Mon Mar 03 08:27:12 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea